The quality of starting materials dramatically influences the properties of the final cellular product. Therefore the ultimate success of your cell product depends on the quality of the raw materials used. For the development of cell-based and gene therapy products regulatory authorities may require the use of strict procedures according to GMP regulations https://www.miltenyibiotec.com/products/cell-manufacturing-platform/macs-gmp-portfolio.html
Join Nicolas Danzenbächer and his webinar on Good Manufacturing Practice (GMP) and learn more about GMP guidelines in different countries and comparable regulations.
MACS Academy: https://www.miltenyibiotec.com/macs-academy
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 2,000 employees in 25 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.